|
Capacity expansion and upgradation of manufacturing facilities |
Working capital requirements |
|
Establishment of a new R&D Centre |
Investment in wholly owned subsidiary, Sai Parenterals Pte Limited (Singapore), in relation to the proposed acquisition of Noumed Pharmaceuticals Pty Limited (Australia) |
|
Repayment / prepayment of certain outstanding borrowings |
General corporate purposes |